LWL University Hospital for Psychiatry, Psychotherapy and Preventive Medicine, Bochum, Germany.
LWL Institute for Mental Health, Bochum, Germany.
Pharmacopsychiatry. 2019 Nov;52(6):261-279. doi: 10.1055/a-0942-1875. Epub 2019 Jul 8.
Dietary supplements are very widely used in the general population and there is a growing market for them, which is against the recommendations of the German Society for Nutrition. There is some evidence that dietary supplements are useful additions in the treatment of psychiatric disorders. This review is an overview of available practical knowledge regarding the use of supplements in psychiatric treatment. In particular, the review focused on the diagnosis of depression and anxiety in terms of supplement treatment.
This is a narrative review of the evidence regarding supplements for treating anxiety and depression. We searched PubMed to 2018. Two reviewers screened the citations and abstracted the data. Phytopharmaceutical attends and animal-based data were excluded.
There are strong indications regarding the impact of supplements on the selected psychiatric disorders, but at this time, there only a few randomized clinical studies available, so evidence for these findings is quite low. However, it must be noted that there are strong hints for a relationship between vitamin D level and depression. Furthermore, various supplements have got potentially an influence on the characteristics of depression.
This review summarizes the current knowledge about supplements when used for some psychiatric conditions, but the data does not provide compelling evidence in any direction. There are only indications that there is an influence of supplements on psychiatric diseases. In support of this, there is further need for high-quality studies in this field. Reviews on other diagnoses, such as schizophrenia and dementia, will be part of further work.
膳食补充剂在普通人群中被广泛使用,而且市场需求不断增长,这与德国营养学会的建议背道而驰。有一些证据表明,膳食补充剂在治疗精神疾病方面是有用的补充。这篇综述概述了关于在精神科治疗中使用补充剂的现有实用知识。特别是,该综述侧重于补充剂治疗抑郁症和焦虑症的诊断。
这是一篇关于治疗焦虑和抑郁的补充剂证据的综述。我们检索了 2018 年以前的 PubMed 数据库。两名评审员筛选了引文和摘要数据。植物药和动物源数据被排除在外。
有强烈的迹象表明补充剂对所选精神障碍有影响,但目前只有少数随机临床试验可用,因此这些发现的证据相当低。然而,必须指出的是,维生素 D 水平与抑郁症之间存在很强的相关性。此外,各种补充剂可能对抑郁症的特征有影响。
本综述总结了目前关于某些精神疾病使用补充剂的知识,但这些数据并没有提供任何方向的有力证据。只有迹象表明补充剂对精神疾病有影响。为此,该领域还需要进一步开展高质量的研究。关于其他诊断,如精神分裂症和痴呆症的综述将是进一步工作的一部分。